Palisade Bio, Inc. (PALI)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 5.71M |
| Enterprise value | -6.35M |
| Trailing P/E | 0.15 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 12.24 |
| Price/book (mrq) | 0.51 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | 0.57 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.35 |
| 52-week change 3 | -71.87% |
| S&P500 52-week change 3 | 26.27% |
| 52-week high 3 | 36.60 |
| 52-week low 3 | 3.82 |
| 50-day moving average 3 | 5.91 |
| 200-day moving average 3 | 9.02 |
Share statistics
| Avg vol (3-month) 3 | 1.15M |
| Avg vol (10-day) 3 | 1.34M |
| Shares outstanding 5 | 851.4k |
| Implied shares outstanding 6 | 851.4k |
| Float 8 | 835.85k |
| % held by insiders 1 | 1.83% |
| % held by institutions 1 | 15.44% |
| Shares short (30 Apr 2024) 4 | 178.48k |
| Short ratio (30 Apr 2024) 4 | 0.07 |
| Short % of float (30 Apr 2024) 4 | 24.55% |
| Short % of shares outstanding (30 Apr 2024) 4 | 20.96% |
| Shares short (prior month 28 Mar 2024) 4 | 1.83k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 18 Jul 2019 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:15 |
| Last split date 3 | 08 Apr 2024 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -5,138.00% |
Management effectiveness
| Return on assets (ttm) | -53.85% |
| Return on equity (ttm) | -103.40% |
Income statement
| Revenue (ttm) | 250k |
| Revenue per share (ttm) | 0.55 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -12.84M |
| Net income avi to common (ttm) | -12.32M |
| Diluted EPS (ttm) | -27.00 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 12.43M |
| Total cash per share (mrq) | 14.6 |
| Total debt (mrq) | 369k |
| Total debt/equity (mrq) | 3.26% |
| Current ratio (mrq) | 5.15 |
| Book value per share (mrq) | 18.30 |
Cash flow statement
| Operating cash flow (ttm) | -11.13M |
| Levered free cash flow (ttm) | -6.47M |
© 2024 Yahoo. All rights reserved.